PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för levofloxacin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

33 hits

Bibliografisk träff 2022-10-31

Pyrvinium pamoate potentiates levofloxacin against levofloxacin-resistant Staphylococcus aureus.

Kaul G, Karale UB, Akhir A, Shukla M, Saxena D, Rode HB, Chopra S.

Future Microbiol · research support, non-u.s. gov't; journal article · DOI 10.2217/fmb-2022-0159

Bibliografisk träff 2022-10-31

Fractionation of levofloxacin and ofloxacin during their transport in NOM-goethite: Batch and column studies.

Qin X, Zhong X, Wang B, Wang G, Liu F, Weng L.

Environ Pollut · journal article · DOI 10.1016/j.envpol.2022.120542

Bibliografisk träff 2022-09-15

Biotransformation of the Fluoroquinolone, Levofloxacin, by the White-Rot Fungus Coriolopsis gallica.

Ben Ayed A, Akrout I, Albert Q, Greff S, Simmler C, Armengaud J, Kielbasa M, Turbé-Doan A, Chaduli D, Navarro D, Bertrand E, Faulds CB, Chamkha M, Maalej A, Zouari-Mechichi H, Sciara G, Mechichi T, Record E.

J Fungi (Basel) · research-article; journal article · DOI 10.3390/jof8090965

Bibliografisk träff 2022-09-14

The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection.

Wang Y, Li C, Wang J, Bai N, Zhang H, Chi Y, Cai Y.

Microbiol Spectr · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/spectrum.01468-22

Bibliografisk träff 2022-09-12

The Influence of Lipid Matrix Composition on the Microenvironment of Levofloxacin in Liposomal Forms.

Le-Deygen IM, Safronova AS, Kolmogorov IM, Skuredina AA, Kudryashova EV.

Russ J Bioorg Chem · research-article; journal article · DOI 10.1134/s1068162022040148

Bibliografisk träff 2022-08-24

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis.

Schwarz C, Procaccianti C, Costa L, Brini R, Friend R, Caivano G, Sadafi H, Mussche C, Schwenck N, Hahn M, Murgia X, Bianco F.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms23179597

Bibliografisk träff 2021-11-25

Structural and functional analysis of the promiscuous AcrB and AdeB efflux pumps suggests different drug binding mechanisms.

Ornik-Cha A, Wilhelm J, Kobylka J, Sjuts H, Vargiu AV, Malloci G, Reitz J, Seybert A, Frangakis AS, Pos KM.

Nat Commun · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/s41467-021-27146-2

Bibliografisk träff 2021-08-11

New chemiluminescent method of levofloxacin and ofloxacin determination based on terbium (III)-sensitized fluoroquinolone-KBrO3 reaction.

Kaczmarek M, Staninski K, Stodolny M.

Luminescence · journal article · DOI 10.1002/bio.4128

Bibliografisk träff 2016-03-24

Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex.

Veselkov DA, Laponogov I, Pan XS, Selvarajah J, Skamrova GB, Branstrom A, Narasimhan J, Prasad JV, Fisher LM, Sanderson MR.

Acta Crystallogr D Struct Biol · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1107/s2059798316001212

Bibliografisk träff 2016-01-20

Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.

Blower TR, Williamson BH, Kerns RJ, Berger JM.

Proc Natl Acad Sci U S A · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1073/pnas.1525047113

Bibliografisk träff 2013-08-21

Structure of an 'open' clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport.

Laponogov I, Veselkov DA, Crevel IM, Pan XS, Fisher LM, Sanderson MR.

Nucleic Acids Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/nar/gkt749

Bibliografisk träff 2012-02-01

Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.

Rimbara E, Noguchi N, Kawai T, Sasatsu M.

Helicobacter · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1523-5378.2011.00912.x

Bibliografisk träff 2011-11-15

In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.

Fukuda Y, Takahata M, Sugiura Y, Shinmura Y, Nomura N.

Int J Antimicrob Agents · comparative study; journal article · DOI 10.1016/j.ijantimicag.2011.09.021

Bibliografisk träff 2011-10-04

Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.

Sonnet P, Izard D, Mullié C.

Int J Antimicrob Agents · journal article · DOI 10.1016/j.ijantimicag.2011.08.005

Bibliografisk träff 2011-09-29

Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain.

Cuadrado-Lavín A, Salcines-Caviedes JR, Carrascosa MF, Mellado P, Monteagudo I, Llorca J, Cobo M, Campos MR, Ayestarán B, Fernández-Pousa A, González-Colominas E.

J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkr410

Bibliografisk träff 2010-11-13

High rates of quinolone resistance among urinary tract infections in the ED.

Khawcharoenporn T, Vasoo S, Ward E, Singh K.

Am J Emerg Med · journal article · DOI 10.1016/j.ajem.2010.09.030

Bibliografisk träff 2010-06-28

Structural basis of gate-DNA breakage and resealing by type II topoisomerases.

Laponogov I, Pan XS, Veselkov DA, McAuley KE, Fisher LM, Sanderson MR.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0011338

Bibliografisk träff 2009-02-01

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM.

Nature · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/nature07762

Bibliografisk träff 2007-10-01

A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.

Zhou ZL, Yang M, Yu XY, Peng HY, Shan ZX, Chen SZ, Lin QX, Liu XY, Chen TF, Zhou SF, Lin SG.

Biomed Chromatogr · research support, non-u.s. gov't; evaluation study; journal article · DOI 10.1002/bmc.851

Bibliografisk träff 2005-07-01

Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung.

Martínez Martínez MS, Gandarillas CI, Martínez Lanao J, Sánchez Navarro A.

J Pharm Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1211/0022357056479

Bibliografisk träff 2003-07-01

Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.

Bielecka-Grzela S, Klimowicz A.

Pol J Pharmacol · comparative study; clinical trial; research support, non-u.s. gov't; journal article

Bibliografisk träff 2002-04-01

Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses.

Chow AT, Chen A, Lattime H, Morgan N, Wong F, Fowler C, Williams RR.

J Clin Pharm Ther · clinical trial; journal article · DOI 10.1046/j.1365-2710.2002.00396.x

Bibliografisk träff 2002-03-01

Clostridium difficile infection associated with levofloxacin treatment.

Ozawa TT, Valadez T.

Tenn Med · journal article

Bibliografisk träff 2001-02-09

Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.

Berning SE, Cherry TA, Iseman MD.

Clin Infect Dis · journal article; case reports · DOI 10.1086/318698

Bibliografisk träff 2001-01-01

[Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].

Budanov SV, Smirnova LB.

Antibiot Khimioter · review; journal article

Bibliografisk träff 2000-11-01

[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].

Kalbermatter V, Bagilet D, Diab M, Javkin E.

Med Clin (Barc) · comparative study; clinical trial; randomized controlled trial; journal article; english abstract · DOI 10.1016/s0025-7753(00)71625-3

Bibliografisk träff 2000-01-01

Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection.

Isogai E, Isogai H, Hayashi S, Kubota T, Kimura K, Fujii N, Ohtani T, Sato K.

Microbiol Immunol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1348-0421.2000.tb01251.x

Bibliografisk träff 1999-11-01

Levofloxacin.

Norrby SR.

Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.1.1.109

Bibliografisk träff 1998-03-01

A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.

Nicodemo AC, Robledo JA, Jasovich A, Neto W.

Int J Clin Pract · clinical trial; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1742-1241.1998.tb11567.x

Bibliografisk träff 1997-02-01

The clinical pharmacokinetics of levofloxacin.

Fish DN, Chow AT.

Clin Pharmacokinet · review; journal article · DOI 10.2165/00003088-199732020-00002

Go to research.

Publications in the selection

Pyrvinium pamoate potentiates levofloxacin against levofloxacin-resistant <i>Staphylococcus aureus</i>.

Fractionation of levofloxacin and ofloxacin during their transport in NOM-goethite: Batch and column studies.

Biotransformation of the Fluoroquinolone, Levofloxacin, by the White-Rot Fungus <i>Coriolopsis gallica</i>.

The Efficacy of Colistin Combined with Amikacin or Levofloxacin against Pseudomonas aeruginosa Biofilm Infection.

The Influence of Lipid Matrix Composition on the Microenvironment of Levofloxacin in Liposomal Forms.

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis.

Structural and functional analysis of the promiscuous AcrB and AdeB efflux pumps suggests different drug binding mechanisms.

New chemiluminescent method of levofloxacin and ofloxacin determination based on terbium (III)-sensitized fluoroquinolone-KBrO<sub>3</sub> reaction.

Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex.

Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.

Structure of an 'open' clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport.

Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB.

In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.

Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.

Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain.

High rates of quinolone resistance among urinary tract infections in the ED.

Structural basis of gate-DNA breakage and resealing by type II topoisomerases.

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.

Comparative study of the disposition of levofloxacin, netilmicin and cefepime in the isolated rat lung.

Evaluation of ofloxacin penetration into the skin after a single oral dose assessed by cutaneous microdialysis.

Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses.

Clostridium difficile infection associated with levofloxacin treatment.

Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.

[Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].

[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].

Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection.

Levofloxacin.

A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.

The clinical pharmacokinetics of levofloxacin.